Published in Immunotherapy Weekly, March 12th, 2003
"Updated progress in our knowledge of tumor-associated antigens and insight into mechanisms involved in immune-mediated recognition of these antigens have provided a strong starting point for using the immune system as a model for novel therapy.
"In this study we determined the immunological profile of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly